NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins

Cells. 2023 May 5;12(9):1319. doi: 10.3390/cells12091319.

Abstract

Background and aims: Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by a T-cell-mediated destruction of the pancreatic insulin-producing beta cells. A growing body of evidence suggests that abnormalities in neutrophils and neutrophil extracellular trap (NET) formation (NETosis) are associated with T1D pathophysiology. However, little information is available on whether these changes are primary neutrophil defects or related to the environmental signals encountered during active disease.

Methods: In the present work, the NET proteome (NETome) of phorbol 12-myristate 13-acetate (PMA)- and ionomycin-stimulated neutrophils from people with established T1D compared to healthy controls (HC) was studied by proteomic analysis.

Results: Levels of NETosis, in addition to plasma levels of pro-inflammatory cytokines and NET markers, were comparable between T1D and HC subjects. However, the T1D NETome was distinct from that of HC in response to both stimuli. Quantitative analysis revealed that the T1D NETome was enriched in proteins belonging to metabolic pathways (i.e., phosphoglycerate kinase, glyceraldehyde-3-phosphate dehydrogenase, and UTP-glucose-1-phosphate uridylyltransferase). Complementary metabolic profiling revealed that the rate of extracellular acidification, an approximate measure for glycolysis, and mitochondrial respiration were similar between T1D and HC neutrophils in response to both stimuli.

Conclusion: The NETome of people with established T1D was enriched in metabolic proteins without an apparent alteration in the bio-energetic profile or dysregulated NETosis. This may reflect an adaptation mechanism employed by activated T1D neutrophils to avoid impaired glycolysis and consequently excessive or suboptimal NETosis, pivotal in innate immune defence and the resolution of inflammation.

Keywords: NET proteome; NETosis; metabolism; neutrophils; type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 1* / metabolism
  • Extracellular Traps* / metabolism
  • Humans
  • Neutrophils / metabolism
  • Proteome / metabolism
  • Proteomics

Substances

  • Proteome

Grants and funding

This work was supported by funding from KU Leuven (C16/18/006), JDRF (1-SRA-2019-809-S-B), and the Flemish Research Foundation (FWO G.0591.23N, a doctoral fellowship for S.B. (11A0220N) and A.C. (1189518N), and a postdoctoral fellowship for MB (3-PDF-2018-593-A-N)). IMI2-JU, under grant agreement No. 115797 (INNODIA) and No. 948268 (INNODIA HARVEST), further supported this work.